[HTML][HTML] The ATLAS randomised clinical trial: what do the superiority results mean for subcutaneous ICD therapy and sudden cardiac death prevention as a whole?
R Rordorf - Arrhythmia & Electrophysiology Review, 2022 - ncbi.nlm.nih.gov
This review sets out the key evidence comparing subcutaneous ICDs (S-ICDs) and
transvenous ICDs and uses it to empower clinical cardiologists and those who implant ICDs …
transvenous ICDs and uses it to empower clinical cardiologists and those who implant ICDs …
Modern subcutaneous implantable defibrillator therapy in patients with cardiomyopathies and channelopathies: data from a large multicentre registry
Aims Patients with cardiomyopathies and channelopathies are usually younger and have a
predominantly arrhythmia-related prognosis; they have nearly normal life expectancy thanks …
predominantly arrhythmia-related prognosis; they have nearly normal life expectancy thanks …
Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator
Aims The implantable cardioverter-defibrillator (ICD) is a life-saving therapy in patients with
hypertrophic cardiomyopathy (HCM) at risk of sudden cardiac death. Implantable …
hypertrophic cardiomyopathy (HCM) at risk of sudden cardiac death. Implantable …
Device-related complications and inappropriate therapies among subcutaneous vs. transvenous implantable defibrillator recipients: insight monaldi rhythm registry
V Russo, A Rago, V Ruggiero, F Cavaliere… - Frontiers in …, 2022 - frontiersin.org
Introduction In the context of randomized clinical trials, subcutaneous implantable cardiac
defibrillators (S-ICDs) are non-inferior to transvenous ICDs (T-ICDs) concerning device …
defibrillators (S-ICDs) are non-inferior to transvenous ICDs (T-ICDs) concerning device …
Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcome
A Segev, Y Wasserstrum, M Arad… - Heart Rhythm, 2023 - Elsevier
Background Hypertrophic cardiomyopathy (HCM) carries an increased risk of sudden
cardiac death. Ventricular fibrillation (VF) is thought to be the common culprit arrhythmia …
cardiac death. Ventricular fibrillation (VF) is thought to be the common culprit arrhythmia …
[HTML][HTML] Subcutaneous versus transvenous implantable cardioverter defibrillator in hypertrophic cardiomyopathy: a systematic review and meta-analysis
ASM Júnior, IC Oliveira, AM de Sousa… - Cardiovascular …, 2024 - ncbi.nlm.nih.gov
Background A subcutaneous implantable cardioverter-defibrillator (S-ICD) is an alternative
to a transvenous implantable cardio defibrillator (TV-ICD). An S-ICD reduces the risk of …
to a transvenous implantable cardio defibrillator (TV-ICD). An S-ICD reduces the risk of …
Differences in underlying cardiac substrate among S-ICD recipients and its impact on long-term device-related outcomes: real-world insights from the iSUSI registry
Background Outcome comparisons among subcutaneous implantable cardioverter-
defibrillator (S-ICD) recipients with nonischemic cardiomyopathies are scarce. Objective The …
defibrillator (S-ICD) recipients with nonischemic cardiomyopathies are scarce. Objective The …
[HTML][HTML] Safety of Sports for Patients with Subcutaneous Implantable Cardioverter Defibrillator (SPORT S-ICD): study rationale and protocol
E Chorin, R Lampert, NR Bijsterveld, RE Knops… - Heart rhythm O2, 2024 - Elsevier
Background Recent studies suggest that participation in recreational and even competitive
sports is generally safe for patients with implantable cardioverter-defibrillators (ICDs) …
sports is generally safe for patients with implantable cardioverter-defibrillators (ICDs) …
Implantable Devices in Genetic Heart Disease: Disease-Specific Device Selection and Programming
S Hansom, Z Laksman - Cardiac Electrophysiology Clinics, 2023 - cardiacep.theclinics.com
The genetic diseases discussed in this article encompass an array of primary arrhythmia
syndromes, channelopathies, and cardiomyopathies. Typically these patients are young …
syndromes, channelopathies, and cardiomyopathies. Typically these patients are young …
Subcutaneous versus Transvenous Implantable Defibrillators: a Systematic Review and Meta-Analysis
M Saleem, V Arshad, P Nabavizadeh… - … American Journal of …, 2024 - search.proquest.com
In patients with complex anatomy, great infection risk, and venous access issues,
subcutaneous implantable cardioverter-defibrillator (S-ICD) is presumed to be an appealing …
subcutaneous implantable cardioverter-defibrillator (S-ICD) is presumed to be an appealing …